Recombinant Human Epidermal Growth Factor (Chengdu Huasun Bio-technology/Institute of Biotechnology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Human Epidermal Growth Factor (Chengdu Huasun Bio-technology/Institute of Biotechnology)
Drug Alias NamerhEGF (Chengdu Huasun Bio-technology/Institute of Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Biotechnology, Academy Of Military Medical Sciences. Pla Of China
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChengdu Huasun Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsCorneal Injuries

Other Information

ATC CodeN/A
Related LinksN/A